Image of Leonid Lecca

Leonid Lecca, M.D.

617-432-1707

Dr. Lecca is an international expert on global health. He earned his MD from Cayetano Heredia Peruvian University, where also holds his MSc in Epidemiology and Health Management. Last year, he participated in the Global Health Intensive Program at Harvard T.H. Chan School of Public Health.

Dr. Lecca is also the Executive Director at Partners In Health in Peru, and serve as the principal investigator for numerous NIH and Grand Challenges of Canada grants among others, oversees a staff of 250, manages relationships with government, and facilitates the participation of students and research affiliates on various projects at the PIH site and throughout Peru. In the past, Dr. Lecca worked as a technical advisor in infectious disease projects at U.S. Agency for International Development, and was the Human Research Protection Administrator at the Peruvian National Institute of Health. 

Leonid Lecca, MD, MSc is a Lecture in the Department of Global Health and Social Medicine at Harvard Medical School. His research focuses on the epidemiology of tuberculosis, multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, HIV/AIDS, maternal-health, mental health, chronic diseases and community-based approaches to dealing with public health problems, social responsibility, and public health approaches in global health. Current projects include:

  • The discovery and development of innovative TB Diagnostics.
  • Finding and treating unsuspected and resistant TB to reduce hospital transmission.
  • Identification of metabolic factors that control the spectrum of human tuberculosis.
  • Clinical trials for TB, MDR-TB and XDR-TB.
  • Study of community-based family coaching interventions to improve neurodevelopment in at-risk children.
  • An innovative interdisciplinary approaches to sustainable airborne infection control.
  • Clinical and programmatic outcomes of a community-based antiretroviral therapy program for HIV positive patients.
Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis.
Authors: Authors: Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.
ERJ Open Res
View full abstract on Pubmed
Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
Authors: Authors: Lecca L, Galea J, Contreras CC, Millones AK, Clendenes M, Yuen CM.
AIDS
View full abstract on Pubmed
Addressing tuberculosis patients' medical and socio-economic needs: a comprehensive programmatic approach.
Authors: Authors: Contreras CC, Millones AK, Santa Cruz J, Aguilar M, Clendenes M, Toranzo M, Llaro K, Lecca L, Becerra MC, Yuen CM.
Trop Med Int Health
View full abstract on Pubmed
Challenges in TB/HIV management in a country with a concentrated HIV epidemic.
Authors: Authors: Lecca L, Galea J, Contreras CC, Millones AK, Clendenes M, Yuen CM.
AIDS
View full abstract on Pubmed
Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Authors: Authors: Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.
Antimicrob Agents Chemother
View full abstract on Pubmed
Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
Authors: Authors: Chiang SS, Roche S, Contreras C, Del Castillo H, Canales P, Jimenez J, Tintaya K, Becerra MC, Lecca L.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Authors: Authors: Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB.
Antimicrob Agents Chemother
View full abstract on Pubmed
Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.
Authors: Authors: Chiang SS, Starke JR, Miller AC, Cruz AT, Del Castillo H, Valdivia WJ, Tunque G, García F, Contreras C, Lecca L, Alarcón VA, Becerra MC.
Clin Infect Dis
View full abstract on Pubmed
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
Authors: Authors: Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD.
BMC Infect Dis
View full abstract on Pubmed
Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.
Authors: Authors: Zelner JL, Murray MB, Becerra MC, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell BT, Cohen T.
J Infect Dis
View full abstract on Pubmed